Potential of plant extracts against Mycobacterium tuberculosis: an integrative review
DOI:
https://doi.org/10.53660/557.prw1608Palavras-chave:
Medicinal Plants, Tuberculosis, MicrobiologyResumo
Mycobacterium tuberculosis (MTB) is the main cause of tuberculosis. For decades, new forms of treatment and new ways of dealing with the growing resistance acquired by this bacterium to first-line drugs have been studied. Medicinal plants are a source of new bioactive compounds with antimicrobial potential. Objective: to investigate which plant species have already been tested and which main secondary metabolites are active against MTB. Methodology: an integrative review that included in vitro experimental studies, carried out around the world, that used medicinal plant extracts to evaluate the antimycobacterial activity by microdilution, with identification of major compounds, against MTB, between 2011 and 2021, the Web of Science and PubMed were used and the descriptors “medicinal plants AND against AND MTB”. Results: 20 species of plants with antimycobacterial activities were found. Four stood out with MIC<10 µg/mL. The variety of secondary metabolites was determinant for antimycobacterial activity, highlighting alkaloids, terpenes and phenolic compounds. Conclusion: the number of secondary metabolites obtained in the extraction is decisive in the antimycobacterial activity.
Downloads
Referências
ABUBAKAR, A. R.; HAQUE, M. Preparation of medicinal plants: Basic extraction and fractionation procedures for experimental purposes. Journal of Pharmacy and Bioallied SciencesWolters Kluwer -- Medknow Publications, , 1 jan. 2020. Disponível em: pmc/articles/PMC7398001. Acesso em: 4 abr. 2022
ALAWI, S. M. AL; HOSSAIN, M. A.; ABUSHAM, A. A. Antimicrobial and cytotoxic comparative study of different extracts of Omani and Sudanese Gum acacia. Beni-Suef University Journal of Basic and Applied Sciences, v. 7, n. 1, p. 22–26, 1 mar. 2018.
AMENGOR, C. D. K. et al. Pyridine-N-Oxide Alkaloids from Allium stipitatum and Their Synthetic Disulfide Analogs as Potential Drug Candidates against Mycobacterium tuberculosis: A Molecular Docking, QSBAR, and ADMET Prediction Approach. BioMed Research International, v. 2022, 2022.
AMORIM, J. C. et al. An in silico evaluation of anthraquinone derivatives as potential inhibitors of DNA gyrase B of Mycobacterium tuberculosis. bioRxiv, v. 10, n. 12, p. 2022.10.01.510436, 8 dez. 2022.
ARCHANA, H.; GEETHA BOSE, V. Evaluation of phytoconstituents from selected medicinal plants and its synergistic antimicrobial activity. Chemosphere, v. 287, p. 132276, 1 jan. 2022.
ASKUN, T. et al. Preliminary antimycobacterial study on selected Turkish plants (Lamiaceae) against Mycobacterium tuberculosis and search for some phenolic constituents. BMC Complementary and Alternative Medicine, v. 13, n. 1, p. 1–11, 21 dez. 2013.
BHATNAGAR, M. et al. Evaluation of antimycobacterial, leishmanicidal and antibacterial activity of three medicinal orchids of Arunachal Pradesh, India. BMC Complementary and Alternative Medicine, v. 17, n. 1, p. 1–10, 1 ago. 2017.
BOSE, P. et al. Tuberculosis: current scenario, drug targets, and future prospects. Medicinal Chemistry Research, v. 30, n. 4, p. 807–833, 1 abr. 2021.
CAESAR, L. K.; CECH, N. B. Synergy and antagonism in natural product extracts: When 1 + 1 does not equal 2Natural Product ReportsThe Royal Society of Chemistry, , 19 jun. 2019. Disponível em: <https://pubs.rsc.org/en/content/articlehtml/2019/np/c9np00011a>. Acesso em: 23 out. 2022
ELOFF, J. N. Avoiding pitfalls in determining antimicrobial activity of plant extracts and publishing the results. BMC Complementary and Alternative MedicineBioMed Central Ltd., , 22 maio 2019. Disponível em: <https://bmccomplementmedtherapies.biomedcentral.com/articles/10.1186/s12906-019-2519-3>. Acesso em: 19 mar. 2022
GEMECHU, A. et al. In vitro Anti-mycobacterial activity of selected medicinal plants against Mycobacterium tuberculosis and Mycobacterium bovis Strains. BMC Complementary and Alternative Medicine, v. 13, n. 1, p. 1–6, 29 out. 2013.
GÓRNIAK, I.; BARTOSZEWSKI, R.; KRÓLICZEWSKI, J. Comprehensive review of antimicrobial activities of plant flavonoids. Phytochemistry ReviewsSpringer Netherlands, , 15 fev. 2019.
GREEN, E. et al. Characterization of n-Hexane sub-fraction of Bridelia micrantha (Berth) and its antimycobacterium activity. BMC Complementary and Alternative Medicine, v. 11, n. 1, p. 1–5, 11 abr. 2011.
GUIMARÃES, A. C. et al. Antibacterial activity of terpenes and terpenoids present in essential oils. Molecules, v. 24, n. 13, p. 2471, 5 jul. 2019.
HAFEZ GHORAN, S. et al. Anthraquinones and Their Analogues from Marine-Derived Fungi: Chemistry and Biological Activities. Marine DrugsMultidisciplinary Digital Publishing Institute, , 25 jul. 2022. Disponível em: <https://www.mdpi.com/1660-3397/20/8/474/htm>. Acesso em: 14 jan. 2023
HARVEY, A. L.; EDRADA-EBEL, R.; QUINN, R. J. The re-emergence of natural products for drug discovery in the genomics era. Nature Reviews Drug Discovery Nature Publishing Group, , 23 jan. 2015. Disponível em: <https://www.nature.com/articles/nrd4510>. Acesso em: 18 out. 2022
IDRIS, F. N.; NADZIR, M. M. Comparative studies on different extraction methods of centella asiatica and extracts bioactive compounds effects on antimicrobial activities. AntibioticsMultidisciplinary Digital Publishing Institute, , 17 abr. 2021. Disponível em: <https://www.mdpi.com/2079-6382/10/4/457/htm>. Acesso em: 18 fev. 2022
JAGATAP, V. R.; AHMAD, I.; PATEL, H. M. Recent updates in natural terpenoids as potential anti-mycobacterial agents. Indian Journal of TuberculosisElsevier, 1 jul. 2022.
KATAEV, V. E. et al. New Targets for Growth Inhibition of Mycobacterium tuberculosis: Why Do Natural Terpenoids Exhibit Antitubercular Activity? Russian Journal of Bioorganic Chemistry, v. 44, n. 4, p. 438–452, 1 jul. 2018.
KEBEDE, T.; GADISA, E.; TUFA, A. Antimicrobial activities evaluation and phytochemical screening of some selected medicinal plants: A possible alternative in the treatment of multidrug-resistant microbes. PLoS ONE, v. 16, n. 3 March, 1 mar. 2021.
KHAWBUNG, J. L.; NATH, D.; CHAKRABORTY, S. Drug resistant Tuberculosis: A review. Comparative Immunology, Microbiology and Infectious Diseases, 2021. Disponível em: <https://doi.org/10.1016/j.cimid.2020.101574>
KOIRALA, N. et al. Medicinal Plants in Targeting Tuberculosis II. In: Medicinal Plants for Lung Diseases. [s.l.] Springer, Singapore, 2021. p. 185–215.
KUETE, V. et al. Antibacterial activities of the extracts, fractions and compounds from Dioscorea bulbifera. BMC Complementary and Alternative Medicine, v. 12, 23 nov. 2012.
KUMAR, M. et al. Potential anti-mycobacterium tuberculosis activity of plant secondary metabolites: Insight with molecular docking interactions. Antioxidants, 2021.
LEITÃO, F. et al. Medicinal plants from open-air markets in the State of Rio de Janeiro, Brazil as a potential source of new antimycobacterial agents. Journal of Ethnopharmacology, v. 149, n. 2, p. 513–521, 16 set. 2013.
LI, Y. et al. The effect of developmental and environmental factors on secondary metabolites in medicinal plants. Plant Physiology and BiochemistryElsevier Masson SAS, , 1 mar. 2020. Disponível em: . Acesso em: 19 mar. 2022
LOZANO, S. A. et al. Duroia saccifera: In vitro germination, friable calli and identification of β-sitosterol and stigmasterol from the active extract against Mycobacterium tuberculosis. Rodriguesia, v. 7, 1 jul. 2020.
LUO, X. et al. Antimycobacterial evaluation and preliminary phytochemical investigation of selected medicinal plants traditionally used in Mozambique. Journal of Ethnopharmacology, v. 137, n. 1, p. 114–120, 2011.
MACABEO, A. P. G. et al. Antitubercular activity of the semi-polar extractives of Uvaria rufa. Asian Pacific Journal of Tropical Medicine, v. 5, n. 10, p. 777–780, out. 2012.
MAKGATHO, M. E.; NXUMALO, W.; RAPHOKO, L. A. Anti-mycobacterial, -oxidative, -proliferative and -inflammatory activities of dichloromethane leaf extracts of Gymnosporia senegalensis (Lam.) Loes. South African Journal of Botany, v. 114, p. 217–222, 1 jan. 2018.
MAPARI, M. et al. Challenges in targeting mycobacterial ATP synthase: The known and beyond. Journal of Molecular StructureElsevier, , 5 jan. 2022.
MARTINS, D. et al. Triterpenes and the antimycobacterial activity of duroia macrophylla huber (Rubiaceae). BioMed Research International, v. 2013, 2013.
MAZLUN, M. H. et al. Phenolic compounds as promising drug candidates in tuberculosis therapy. MoleculesMultidisciplinary Digital Publishing Institute, , 4 jul. 2019. Disponível em: <https://www.mdpi.com/1420-3049/24/13/2449/htm>. Acesso em: 22 jan. 2023
MOHAMAD, S. et al. Antituberculosis activity, phytochemical identification of Costus speciosus (J. Koenig) Sm., Cymbopogon citratus (DC. Ex Nees) Stapf., and Tabernaemontana coronaria (L.) Willd. and their effects on the growth kinetics and cellular integrity of Mycobacteri. BMC Complementary and Alternative Medicine, v. 18, n. 1, 8 jan. 2018.
MOLINA-SALINAS, G. M. et al. Evaluation of the flora of Northern Mexico for in vitro antimicrobial and antituberculosis activity. Journal of Ethnopharmacology, v. 109, n. 3, p. 435–441, 12 fev. 2007.
NEWMAN, D. J.; CRAGG, G. M. Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. Journal of Natural ProductsAmerican Chemical Society, , 27 mar. 2020. Disponível em: <https://pubs.acs.org/doi/abs/10.1021/acs.jnatprod.9b01285>. Acesso em: 18 out. 2022
RABAHI, M. F. et al. Tuberculosis treatment. Jornal Brasileiro de PneumologiaSociedade Brasileira de Pneumologia e Tisiologia, , 1 nov. 2017. Disponível em: <http://www.scielo.br/j/jbpneu/a/fr4LscGzFpJFSm6P4Hd5gXL/?lang=pt>. Acesso em: 12 out. 2022
REIS, A. J. et al. Avaliação das atividades antifúngica, antimicobacteriana e larvicida de Duroia macrophylla e D. saccifera. Revista de Epidemiologia e Controle de Infecção, v. 1, n. 1, 2016.
SCAINI, J. L. R. et al. Molecular modelling and competitive inhibition of a Mycobacterium tuberculosis multidrug-resistance efflux pump. Journal of Molecular Graphics and Modelling, v. 87, p. 98–108, 1 mar. 2019.
SHARIFI-RAD, J. et al. Medicinal plants used in the treatment of tuberculosis - Ethnobotanical and ethnopharmacological approaches. Biotechnology Advances, v. 44, n. July 2017, p. 107629, 2020.
STEPHANIE, F.; SARAGIH, M.; TAMBUNAN, U. S. F. Recent progress and challenges for drug-resistant tuberculosis treatment. Pharmaceutics, 2021. Disponível em: <https://doi.org/10.3390/pharmaceutics13050592>
TIAN, F. et al. Antioxidant and antimicrobial activities of consecutive extracts from Galla chinensis:The polarity affects the bioactivities. Food Chemistry, v. 113, n. 1, p. 173–179, 1 mar. 2009.
TRIVELLINI, A. et al. Lamiaceae phenols as multifaceted compounds: Bioactivity, industrial prospects and role of “positive-stress”. Industrial Crops and ProductsElsevier, , 1 maio 2016.
WHITTEMORE, R.; KNAFL, K. The integrative review: Updated methodology. Journal of Advanced Nursing, dez. 2005.
WHO, W. H. O. TB deaths and incidenceGlobal tuberculosis report. [s.l.] World Health Organization, 2021.
WHO, W. H. O. GLOBAL TUBERCULOSIS REPORT 2022. [s.l: s.n.]. v. 8
